Select Equity Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,524,793
| Closed | -$36.1M | – | 178 |
|
|
2022
Q4 | $36.1M | Sell |
2,524,793
-13,926,045
| -85% | -$199M | 0.14% | 88 |
|
|
2022
Q3 | $420M | Sell |
16,450,838
-2,664,088
| -14% | -$68M | 1.46% | 22 |
|
|
2022
Q2 | $543M | Buy |
19,114,926
+14,870
| +0.1% | +$422K | 1.74% | 14 |
|
|
2022
Q1 | $674M | Sell |
19,100,056
-1,442,447
| -7% | -$50.9M | 2.18% | 14 |
|
|
2021
Q4 | $861M | Buy |
20,542,503
+8,420,492
| +69% | +$353M | 2.35% | 11 |
|
|
2021
Q3 | $595M | Buy |
12,122,011
+4,277,119
| +55% | +$210M | 2% | 17 |
|
|
2021
Q2 | $327M | Buy |
7,844,892
+3,242,543
| +70% | +$135M | 1.12% | 31 |
|
|
2021
Q1 | $164M | Buy |
4,602,349
+3,993,858
| +656% | +$142M | 0.6% | 45 |
|
|
2020
Q4 | $17.1M | Buy |
+608,491
| New | +$17.1M | 0.07% | 89 |
|